Virion Therapeutics' Series A Round

Virion Therapeutics raised a round of funding on July 19, 2018.

Virion Therapeutics is developing immune-based treatments for virally-associated cancers and chronic viral infections. Its vaccines, ChiVax and ChiVax-gD, represent platforms to induce potent and sust…

Articles about Virion Therapeutics' Series A Round: